NCT04843449View on ClinicalTrials.gov

Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 4, 2021

Primary Completion Date

May 6, 2021

Study Completion Date

May 14, 2021

Conditions
Healthy
Interventions
DRUG

ASC40

Oral tablets

DRUG

Itraconazole

Oral capsules

DRUG

rifampicin

Oral capsules

Trial Locations (1)

Unknown

Hunan provincial people's hospital, Changsha

Sponsors
All Listed Sponsors
lead

Ascletis Pharmaceuticals Co., Ltd.

INDUSTRY